Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis.
about
Movement Disorders Following Cerebrovascular Lesion in the Basal Ganglia CircuitThe role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2Vascular Parkinsonism: deconstructing a syndrome.Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans.Vascular parkinsonism--characteristics, pathogenesis and treatment.Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease.123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.White matter lesions in Parkinson disease.Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol.The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism.A retrospective study of the clinical and electrophysiological characteristics of 32 patients with orthostatic myoclonus.MRI features of Binswanger's disease predict prognosis and associated pathologyCerebrovascular disease pathology and parkinsonian signs in old age.Midbrain atrophy in vascular Parkinsonism.Androgens exacerbate motor asymmetry in male rats with unilateral 6-hydroxydopamine lesion.Significance of Haemodynamic and Haemostatic Factors in the Course of Different Manifestations of Cerebral Small Vessel Disease: The SHEF-CSVD Study-Study Rationale and Protocol.Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism.Contribution of routine brain MRI to the differential diagnosis of parkinsonism: a 3-year prospective follow-up study.Ten steps to identify atypical parkinsonismCerebral small vessel disease and incident parkinsonism: The RUN DMC study.Low Cerebral Glucose Metabolism: A Potential Predictor for the Severity of Vascular Parkinsonism and Parkinson's Disease.Approach to diagnosis of Parkinson disease.White matter hyperintensity burden on magnetic resonance imaging in essential tremor.Associations between mobility, cognition and callosal integrity in people with parkinsonismVitamin D reduces falls and hip fractures in vascular Parkinsonism but not in Parkinson's disease.Evaluation of Nonmotor Symptoms in Diagnosis of Parkinsonism and Tremor.Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson's Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot StudySingle photon-emission computed tomography imaging in early Parkinson's disease.Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls.Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review.What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?The clinical manifestations and pathophysiology of cerebral small vessel diseaseMilestones in atypical and secondary Parkinsonisms.Parkinson's disease and parkinsonism: neuropathology.Combined assessment of midbrain hyperechogenicity, hyposmia and motor asymmetry improves diagnostic accuracy in early Parkinson's disease.Movement disorders after stroke in adults: a review.Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.Vascular parkinsonism or idiopathic NPH? New insights from CSF pressure analysis.
P2860
Q26744786-41D47A8F-D3D4-4754-B0E3-24571BC0F410Q27011665-6CABC8B0-ED08-490E-A834-CDD56EA4C138Q27333064-4C06C7AA-A08C-4CE2-8436-B33AF556270CQ30588544-AA13A26B-BFAB-46D0-89FE-201A8B426816Q30851659-09B9960B-211E-41A6-BB1D-8B8ADE7256A0Q30940108-6E07A715-3B4C-4A66-83A7-63392C26FA13Q33571889-2744FB4F-96F5-4191-8567-BDFCFA59757EQ33760571-44F977C5-A840-4B4F-8FC1-6B258C699EDFQ33827305-D8780B3B-ABEB-4027-9D3C-E0A908867C61Q33831084-098F192B-7ABE-4FEB-85DA-CB54433072E7Q33893957-2A95C87F-644C-4768-89CA-4FC90A2CBC9DQ34016992-C575CF28-ADD8-4D36-B676-221C22429D5FQ34562869-1E54EBF2-2317-4338-8408-B0F80811EADFQ35448970-A231DA7C-7E68-41D3-BB96-ACA2851A4064Q35460001-13C9A8BA-6351-4DFE-92CA-0155CC38CCD5Q35534149-321ED593-3484-410D-ACA8-52CBE9C86413Q35623248-86C300AD-C010-45D2-A072-BBDE26F9FFA5Q35829608-A83EE3B8-9990-4B35-8FF8-6795A4065B80Q35985340-07A0925A-70BF-4DCA-A92C-77A0E5084981Q36141969-CF7346B8-D4C6-4A84-9AA1-4B035AB09489Q36272242-A94C457A-4F44-4E83-BF25-00ACE015878DQ36314846-A372C1B2-5FD6-4446-8101-21FED80C3DACQ36558596-1DFB18C1-8888-4896-B8AA-AA3750566453Q36603099-61F65C72-02C7-4E7D-863D-D3A3BDC84749Q36787337-0AAFB5E9-9B65-4589-A957-5ABCD52E8633Q36803644-D5ED5BEB-71BA-4E29-8C7F-11121C548143Q37043936-FD01E726-9B47-4136-A753-BF0C4F73A47FQ37155510-F7DF29A9-B008-4292-BC95-21A38E8E80A8Q37352055-FBFB1D0C-22CD-4C20-8EAA-EAD6A860D8EDQ37415178-43188FE4-6DF3-4451-9F21-F0896D7EB7ACQ37676109-31B83459-366E-428D-AD06-D1A96BE54D30Q37682763-F24009EF-0F8F-416B-B799-AA643FDCC0BDQ37760792-977D552F-1BCC-4EE5-8E7C-BA1418FCC569Q37882597-F8E5B06C-4863-4DB6-9AB7-EE482129C8DCQ38036232-9D005EDC-C370-40EB-A1F4-18AA40FC4D9EQ38045906-9F88F535-09FA-49EE-A9F1-78F046F0894CQ38084627-14D3E825-08CA-41A5-8DF8-B5B12075D426Q38385278-ECC11962-5574-40E8-9BD1-C522D50BBF92Q38492560-4584B067-34FE-4CBC-8F80-3474C8825DF8Q38613052-CCF1DA70-61E8-4A9E-ADA8-633D97F031E8
P2860
Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Clinicopathological investigat ...... inical criteria for diagnosis.
@ast
Clinicopathological investigat ...... inical criteria for diagnosis.
@en
type
label
Clinicopathological investigat ...... inical criteria for diagnosis.
@ast
Clinicopathological investigat ...... inical criteria for diagnosis.
@en
prefLabel
Clinicopathological investigat ...... inical criteria for diagnosis.
@ast
Clinicopathological investigat ...... inical criteria for diagnosis.
@en
P2093
P2860
P356
P1433
P1476
Clinicopathological investigat ...... inical criteria for diagnosis.
@en
P2093
Andrew J Hughes
Jan C M Zijlmans
Susan E Daniel
Tamas Révész
P2860
P304
P356
10.1002/MDS.20083
P407
P577
2004-06-01T00:00:00Z